These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 34923951)

  • 21. Resveratrol protects diabetic kidney by attenuating hyperglycemia-mediated oxidative stress and renal inflammatory cytokines via Nrf2-Keap1 signaling.
    Palsamy P; Subramanian S
    Biochim Biophys Acta; 2011 Jul; 1812(7):719-31. PubMed ID: 21439372
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ponicidin attenuates streptozotocin-induced diabetic nephropathy in rats via modulating hyperlipidemia, oxidative stress, and inflammatory markers.
    An S; Li Y; Jia X; Yang Y; Jia X; Jia X; Xue W
    J Biochem Mol Toxicol; 2022 Apr; 36(4):e22988. PubMed ID: 35187780
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lysophosphatidic acid receptor 1 inhibitor, AM095, attenuates diabetic nephropathy in mice by downregulation of TLR4/NF-κB signaling and NADPH oxidase.
    Lee JH; Sarker MK; Choi H; Shin D; Kim D; Jun HS
    Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1332-1340. PubMed ID: 30763641
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antioxidant and Antiapoptotic effect of aqueous extract of Pueraria tuberosa (Roxb. Ex Willd.) DC. On streptozotocin-induced diabetic nephropathy in rats.
    Shukla R; Banerjee S; Tripathi YB
    BMC Complement Altern Med; 2018 May; 18(1):156. PubMed ID: 29751837
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oxidative stress in diabetic nephropathy.
    Kashihara N; Haruna Y; Kondeti VK; Kanwar YS
    Curr Med Chem; 2010; 17(34):4256-69. PubMed ID: 20939814
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autophagy and its therapeutic potential in diabetic nephropathy.
    Han YP; Liu LJ; Yan JL; Chen MY; Meng XF; Zhou XR; Qian LB
    Front Endocrinol (Lausanne); 2023; 14():1139444. PubMed ID: 37020591
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potential therapeutic value of melatonin in diabetic nephropathy: improvement beyond anti-oxidative stress.
    Guo C; He J; Deng X; Wang D; Yuan G
    Arch Physiol Biochem; 2023 Dec; 129(6):1250-1261. PubMed ID: 34048666
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Astragaloside IV acts through multi-scale mechanisms to effectively reduce diabetic nephropathy.
    Wang E; Wang L; Ding R; Zhai M; Ge R; Zhou P; Wang T; Fang H; Wang J; Huang J
    Pharmacol Res; 2020 Jul; 157():104831. PubMed ID: 32339782
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An examination of the protective effects and molecular mechanisms of curcumin, a polyphenol curcuminoid in diabetic nephropathy.
    Zhu X; Xu X; Du C; Su Y; Yin L; Tan X; Liu H; Wang Y; Xu L; Xu X
    Biomed Pharmacother; 2022 Sep; 153():113438. PubMed ID: 36076553
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nrf2 signaling in diabetic nephropathy, cardiomyopathy and neuropathy: Therapeutic targeting, challenges and future prospective.
    Hashemi M; Zandieh MA; Ziaolhagh S; Mojtabavi S; Sadi FH; Koohpar ZK; Ghanbarirad M; Haghighatfard A; Behroozaghdam M; Khorrami R; Nabavi N; Ren J; Reiter RJ; Salimimoghadam S; Rashidi M; Hushmandi K; Taheriazam A; Entezari M
    Biochim Biophys Acta Mol Basis Dis; 2023 Jun; 1869(5):166714. PubMed ID: 37028606
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mitochondrial Dysfunction and Diabetic Nephropathy: Nontraditional Therapeutic Opportunities.
    Zhang PN; Zhou MQ; Guo J; Zheng HJ; Tang J; Zhang C; Liu YN; Liu WJ; Wang YX
    J Diabetes Res; 2021; 2021():1010268. PubMed ID: 34926696
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protective effect of the ethanol extract from Ligusticum chuanxiong rhizome against streptozotocin-induced diabetic nephropathy in mice.
    Yang WJ; Li YR; Gao H; Wu XY; Wang XL; Wang XN; Xiang L; Ren DM; Lou HX; Shen T
    J Ethnopharmacol; 2018 Dec; 227():166-175. PubMed ID: 30176347
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insights into the Therapeutic and Pharmacological Properties of Resveratrol as a Nutraceutical Antioxidant Polyphenol in Health Promotion and Disease Prevention.
    Mohammadi S; Moghadam MD; Nasiriasl M; Akhzari M; Barazesh M
    Curr Rev Clin Exp Pharmacol; 2024; 19(4):327-354. PubMed ID: 38192151
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation of Renal Insulin Signaling Pathway and Antioxidant Enzymes with Streptozotocin-Induced Diabetes: Effects of Resveratrol.
    Sadi G; Şahin G; Bostancı A
    Medicina (Kaunas); 2018 Dec; 55(1):. PubMed ID: 30602713
    [No Abstract]   [Full Text] [Related]  

  • 35. Ursolic acid improves diabetic nephropathy via suppression of oxidative stress and inflammation in streptozotocin-induced rats.
    Xu HL; Wang XT; Cheng Y; Zhao JG; Zhou YJ; Yang JJ; Qi MY
    Biomed Pharmacother; 2018 Sep; 105():915-921. PubMed ID: 30021385
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Baicalin Alleviates Oxidative Stress and Inflammation in Diabetic Nephropathy via Nrf2 and MAPK Signaling Pathway.
    Ma L; Wu F; Shao Q; Chen G; Xu L; Lu F
    Drug Des Devel Ther; 2021; 15():3207-3221. PubMed ID: 34321869
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting oxidative stress and anti-oxidant defence in diabetic kidney disease.
    Østergaard JA; Cooper ME; Jandeleit-Dahm KAM
    J Nephrol; 2020 Oct; 33(5):917-929. PubMed ID: 32447617
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ferroptosis: an important player in the inflammatory response in diabetic nephropathy.
    Li J; Li L; Zhang Z; Chen P; Shu H; Yang C; Chu Y; Liu J
    Front Immunol; 2023; 14():1294317. PubMed ID: 38111578
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kidney-targeted astaxanthin natural antioxidant nanosystem for diabetic nephropathy therapy.
    Chen Z; Li W; Shi L; Jiang L; Li M; Zhang C; Peng H
    Eur J Pharm Biopharm; 2020 Nov; 156():143-154. PubMed ID: 32937179
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hydrogen sulfide modulates SIRT1 and suppresses oxidative stress in diabetic nephropathy.
    Ahmed HH; Taha FM; Omar HS; Elwi HM; Abdelnasser M
    Mol Cell Biochem; 2019 Jul; 457(1-2):1-9. PubMed ID: 30778838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.